Despite positive results from a Phase I/II trial of its investigational pandemic influenza vaccine, mRNA-1018, Moderna’s ...

HHS has notified Moderna that it is canceling a nearly $600 million contract for vaccines for flu strains that could trigger ...

The funding was meant to help the U.S. prepare for pandemics triggered by avian flu strains, but now leaves the future of ...

In a startling pandemic preparedness development, Moderna yesterday announced that the US Department of Health and Human ...

Trump HHS ends nearly $1 billion in funding to Moderna for mRNA bird flu vaccines, citing safety concerns and lack of ...

The Trump administration canceled a nearly $600 million award to Moderna to develop an mRNA vaccine for bird flu in humans, ...

The award from the Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and ...

The department cited Moderna’s use of the messenger RNA technology, which it said “remains under-tested,” for the ...

The Trump administration said it was cancelling $766 million in funding for a Moderna vaccine contract that was supposed to ...

In today's Pharmalittle roundup, we're reading about HHS canceling a Moderna contract, FDA rejecting a rare disease drug, and ...

The federal Department of Health and Human Services is pulling support for Moderna’s work on a potential bird flu vaccine, ...

Moderna will not be developing a vaccine to protect against bird flu — at least on the federal government’s dime. The U.S.